Skip to main content

Glia

ApplicationLondon, CanadaFounded 2016· One of 313 Application companies tracked by AMPulse

An open-source medical hardware project that develops and manufactures high-quality, clinically validated medical devices using 3D printing to bypass supply chain barriers in resource-scarce environments.

CEO / Founder
Daniel Michaeli
Team Size
11-50
Stage
Active
Total Funding
$1.03M
Latest Round
Series D
Key Investors
Shuttleworth Foundation, Bassel Khartabil Fellowship, Western University, Grand Challenges Canada, Finn AI

Technology & Products

Key Products

Open-source medical devices including stethoscopes, otoscopes, tourniquets, and the Kidney-CAP.

Technological Advantage

Combines rigorous clinical validation (matching the performance of industry leaders like Littmann) with distributed manufacturing; this allows for the production of life-saving tools on-site using standard 3D printers and recycled materials.

Differentiation

Value Proposition

Delivers medical-grade equipment at a fraction of the cost of traditional proprietary hardware by utilizing local 3D printing and open-source designs, effectively overcoming international blockades and logistics failures.

How They Differentiate

Glia utilizes open-source hardware (OSH) licenses and decentralized 3D printing to produce medical-grade devices that are clinically validated to match the performance of industry leaders at a fraction of the cost (e.g., a $5 stethoscope vs. a $200 Littmann).

Market & Competition

Target Customers

Humanitarian organizations (NGOs), hospitals in conflict zones or low-resource settings, and medical practitioners in underserved regions.

Industry Verticals

["Medical Devices","Humanitarian Aid & Disaster Relief","Additive Manufacturing (3D Printing)","Global Health & Social Enterprise"]

Competitors

Traditional proprietary medical device manufacturers (e.g., Littmann).

Growth & Milestones

Growth Metrics

Produced over 10,000 face shields during COVID-19; 500+ stethoscopes in active clinical use; 100% clinical equivalence to premium diagnostic tools.

Major Milestones

["Published world's first clinical validation of a 3D-printed stethoscope in 2015","Established the first 3D-printing medical manufacturing hub in Gaza in 2018","Successfully deployed 3D-printed external fixators for blast injuries in Gaza in 2024"]

Notable Customers

Hospitals in resource-scarce environments, Open Gaza Initiative.